BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19242497)

  • 1. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions.
    Mullighan CG; Downing JR
    Leukemia; 2009 Jul; 23(7):1209-18. PubMed ID: 19242497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of high-risk acute lymphoblastic leukemia.
    Collins-Underwood JR; Mullighan CG
    Leukemia; 2010 Oct; 24(10):1676-85. PubMed ID: 20739952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
    Roberts KG; Mullighan CG
    Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of acute leukemia.
    Mullighan CG
    Int J Lab Hematol; 2009 Aug; 31(4):384-97. PubMed ID: 19486196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations targeting lymphoid development in acute lymphoblastic leukemia.
    Collins-Underwood JR; Mullighan CG
    Curr Top Dev Biol; 2011; 94():171-96. PubMed ID: 21295687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.
    Martinelli G; Iacobucci I; Soverini S; Piccaluga PP; Cilloni D; Pane F
    Expert Rev Hematol; 2009 Jun; 2(3):297-303. PubMed ID: 21082971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetic makeup of acute lymphoblastic leukemia.
    Mullighan CG
    Hematology Am Soc Hematol Educ Program; 2012; 2012():389-96. PubMed ID: 23233609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving outcomes for high-risk ALL: translating new discoveries into clinical care.
    Hunger SP; Raetz EA; Loh ML; Mullighan CG
    Pediatr Blood Cancer; 2011 Jun; 56(6):984-93. PubMed ID: 21370430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.
    Juric D; Lacayo NJ; Ramsey MC; Racevskis J; Wiernik PH; Rowe JM; Goldstone AH; O'Dwyer PJ; Paietta E; Sikic BI
    J Clin Oncol; 2007 Apr; 25(11):1341-9. PubMed ID: 17312329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
    Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
    Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.
    Irving JA; Bloodworth L; Bown NP; Case MC; Hogarth LA; Hall AG
    Cancer Res; 2005 Apr; 65(8):3053-8. PubMed ID: 15833833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy.
    Loh ML; Mullighan CG
    Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; FoĆ  R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of B-progenitor acute lymphoblastic leukemia.
    Mullighan CG
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):489-503. PubMed ID: 22127311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
    Rubnitz JE
    J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood acute lymphoblastic leukemia in the age of genomics.
    Carroll WL; Bhojwani D; Min DJ; Moskowitz N; Raetz EA
    Pediatr Blood Cancer; 2006 May; 46(5):570-8. PubMed ID: 16365862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic events in adult acute lymphoblastic leukemia.
    Gleissner B; Thiel E
    Expert Rev Mol Diagn; 2003 May; 3(3):339-55. PubMed ID: 12779008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of childhood acute lymphoblastic leukemia.
    Lo Nigro L
    J Pediatr Hematol Oncol; 2013 May; 35(4):245-52. PubMed ID: 23612374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide SNP analysis in cancer: leukemia shows the way.
    Wang Y; Armstrong SA
    Cancer Cell; 2007 Apr; 11(4):308-9. PubMed ID: 17418407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.